1 2 3 4 5 6 7 8 9 10 11 10 12 13 14 15 16 17 18 19 20 21
, , , ,,, , , , , , , , , , , , , , , , ,
1
Schmidt J, Strauss GP, Schon A, Luz A, Murray AB, Melchiori A et al. Establishment and
characterization of osteogenic cell lines from a spontaneous murine osteosarcoma. Differentiation
1988; 39: 151–160.
2
Gerstenfeld LC, Uporova T, Schmidt J, Strauss PG, Shih SD, Huang LF et al. Osteogenic potential
of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo
conditions. Lab Invest 1996; 74: 895–906.
3
Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L. An orthotopic model of murine
osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp
Metastasis 2000; 18: 261–271.
4
Dunn TB, Andervont HB. Histology of Some Neoplasms and Non-Neoplastic Lesions Found in
Wild Mice Maintained under Laboratory Conditions. J Natl Cancer Inst 1963; 31: 873–901.
5
Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S et al. Establishment and characterization of a
murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 1998;
76: 418–422.
6
Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283: 139–146.
7
NITTO H, KOSHINO T, MITSUGI N, HIRUMA T. Growth of a murine osteosarcoma-derived
cell sarcoma increases serum immunosuppressive acidic protein levels. Cancer J 1998; 11: 254–
258.
8
Uesugi M, Koshino T, Mitsugi N, Hiruma T. Predictive value of serum immunosuppressive acidic
protein for lung metastasis after amputation of murine osteosarcoma of the lower limb. Cancer Lett
2000; 155: 169–172.
9
Joliat MJ, Umeda S, Lyons BL, Lynes MA, Shultz LD. Establishment and characterization of a
new osteogenic cell line (MOS-J) from a spontaneous C57BL/6J mouse osteosarcoma. In Vivo
(Brooklyn) 2002; 16: 223–228.
10
McAllister RM, Gardner MB, Greene AE, Bradt C, Nichols WW, Landing BH. Cultivation in vitro
of cells derived from a human osteosarcoma. Cancer 1971; 27: 397–402.
11
Rhim JS, Park DK, Arnstein P, Huebner RJ, Weisburger EK, Nelson-Rees WA. Transformation of
human cells in culture by N-methyl-N’-nitro-N-nitrosoguanidine. Nature 1975; 256: 751–753.
12
Rhim JS, Cho HY, Vernon ML, Arnstein P, Huebner RJ, Gilden R V. Characterization of nonproducer human cells induced by Kirsten sarcoma virus. Int J Cancer 1975; 16: 840–849.
13
Rhim JS, Cho HY, Huebner RJ. Non-producer human cells induced by murine sarcoma virus. Int J
Cancer 1975; 15: 23–29.
14
Berlin O, Samid D, Donthineni-Rao R, Akeson W, Amiel D, Woods Jr. VL. Development of a
novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone
of athymic mice. Cancer Res 1993; 53: 4890–4895.
15
Campione-Piccardo J, Rawls WE, Bacchetti S. Selective assay for herpes simplex viruses
expressing thymidine kinase. J Virol 1979; 31: 281–287.
16
Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W et al. An orthotopic model of human
osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 2005; 22: 319–
329.
17
Ponten J, Saksela E. Two established in vitro cell lines from human mesenchymal tumours. Int J
Cancer 1967; 2: 434–447.
18
Manara MC, Baldini N, Serra M, Lollini PL, De Giovanni C, Vaccari M et al. Reversal of
malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene.
Bone 2000; 26: 215–220.
19
Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines
producing tumors in nude mice. J Natl Cancer Inst 1977; 59: 221–226.
20
Billiau A, Edy VG, Heremans H, Van Damme J, Desmyter J, Georgiades JA et al. Human
interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother
1977; 12: 11–15.
21
Cheon J, Ko SC, Gardner TA, Shirakawa T, Gotoh A, Kao C et al. Chemogene therapy: osteocalcin
promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma
model. Cancer Gene Ther 1997; 4: 359–365.